Latest Therapeutic hypothermia Stories
Cardium Therapeutics (OTCBB:CDTP) and its operating unit, InnerCool Therapies, today announced that temperature modulation therapy in cardiac arrest patients was featured in Newsweek's July 23 cover story. The article, "This Man Was Dead.
Cardium Therapeutics (OTCBB:CDTP) and its subsidiary InnerCool Therapies announced today the enrollment of the first patient in the RAPID MI-ICE study at Lund University Hospital in Sweden.
Cardium Therapeutics (OTCBB:CDTP) and its subsidiary InnerCool Therapies announced today that its endovascular temperature modulation technology was featured in the March 2007 issue of Men's Health.
Patients suffering from a stroke are more likely to have improved outcomes and fewer complications when hospitals use standardized guidelines for stroke care during a patient's admission and discharge from the hospital, according to a study led by researchers at UCSF Medical Center. The study results appear in the August 9 issue of Neurology.